Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Supernus Pharmaceuticals (SUPN) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Spn-821 2400 MgMajor Depressive Disorder (Mdd)Phase IIRecruitingDouble-blind, Placebo-controlled Study in Adults With Major Depressive DisorderNov 07, 2025―
Spn-817Focal Onset SeizuresPhase IIRecruitingSPN-817 Open-Label Extension Study in Adults With Focal Onset SeizuresAug 19, 2025
Spn-817Focal Onset SeizuresPhase IIRecruitingRENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset SeizuresJan 16, 2025
Nv-5138Major Depressive DisorderPhase IICompletedOpen-Label of SPN-820 in Adults With Major Depressive DisorderJan 23, 2024―
Spn-812Attention-Deficit/Hyperactivity DisorderPhase IVActive Not RecruitingOpen-label Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD and Mood SymptomsDec 15, 2023―
BrexanoloneTinnitusPhase IICompletedAn Open-Label Study Evaluating Brexanolone in Adults With TinnitusDec 01, 2022―
Sage-718Alzheimer's Disease, Mild Cognitive Impairment, Mild DementiaPhase IICompletedA Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)Nov 09, 2022―
Sage-718Huntington DiseasePhase IICompleted28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's DiseaseApr 27, 2022―
Sage-718Parkinson Disease, Cognitive DysfunctionPhase IICompletedA Study to Evaluate the Effects of SAGE-718 in Participants With Parkinson's Disease Cognitive ImpairmentApr 01, 2022―
Sage-718Huntington's DiseasePhase IICompletedA Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)Oct 25, 2021―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Supernus Pharmaceuticals (SUPN) have in its pipeline
Supernus Pharmaceuticals SUPN is currently developing the following drugs: Spn-821 2400 Mg, Spn-817, Nv-5138, Spn-812, Brexanolone, Sage-718, Zulresso, Ketamine, Sage-904, 100Mg Spn-812, Functional Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy, Point Subtraction Aggression Paradigm Task, Spn-810, Sage-547 90 Μg/Kg/H, Sage-547 90 Μg/Kg/H, Sage-547 60 Μg/Kg/H, Sage-547, Spn-810. These drug candidates are in various stages of clinical development as the company works toward FDA approval.